Loading chat...
MO SB1582
Bill
Status
1/22/2026
Primary Sponsor
Kurtis Gregory
Click for details
AI Summary
-
University of Missouri must establish a governance board to oversee radiotheranostics research for treating rare pediatric diseases (conditions affecting fewer than 200,000 individuals under age 18)
-
Board membership includes representatives from the MU School of Medicine, MURR research reactor, Ellis Fischel Cancer Center, NextGen Precision Health, one appointee each from the House and Senate, a patient/family advocate, and a nonprofit or industry partner
-
Annual public report required to the General Assembly by December 31 each year covering research projects initiated and completed, key outcomes, funds expended, and legislative recommendations
-
Section expires on June 30, 2030
Legislative Description
Establishes a University of Missouri governance board for reporting on research related to rare pediatric diseases
Last Action
Second Read and Referred S Families, Seniors and Health Committee
2/5/2026